Tetracyclines

Therapeutic indications Doxycycline, Treatment of the following infections caused by susceptible microorganisms: atypical pneumonia caused by Mycoplasma pneumoniae and Chlamydia pneumoniae; psittacosis; uncomplicated nongonococcal urethritis, cervicitis, and proctitis; lymphogranuloma venereum; granuloma inguinale (donovanosis); pelvic inflammatory disease; stages 1 and 2 of syphilis, as well as late and latent syphilis, in patients allergic to penicillin; acute orchiepididymitis; trachoma; inclusion conjunctivitis; infections caused by rickettsiae such as Rocky Mountain spotted fever, Mediterranean fever, typhus (endemic and scrub typhus), and Q fever; brucellosis (in combination with streptomycin); cholera; Lyme disease (early stages 1 and 2); Relapsing fevers transmitted by lice and ticks; malaria caused by chloroquine-resistant Plasmodium falciparum. - Alternative treatment for: anthrax (cutaneous, intestinal, or pulmonary), tularemia, listeriosis, bartonellosis, and actinomycosis. - Adjuvant in the treatment of severe acne vulgaris. - Prophylaxis of: malaria caused by Plasmodium falciparum in areas with mefloquine resistance or when other antimalarials cannot be used in areas with chloroquine resistance, and post-exposure prophylaxis against Bacillus anthracis, as an alternative treatment to quinolones. Modified-release formulations: to reduce papulopustular lesions in adults with facial rosacea. VItae Laboratory